Newsletter and Subscription Sign Up
Subscribe

Harvard Pilgrim to Offer $40,000 in Grants for Opioid Misuse Prevention and Treatment

Published Tuesday May 15, 2018

Harvard Pilgrim to Offer $40,000 in Grants for Opioid Misuse Prevention and Treatment

Harvard Pilgrim Health Care  has launched a $40,000 opioid misuse prevention, recovery and treatment grants program. Funded by the Harvard Pilgrim Health Care Foundation, the program will offer individual grants up to $10,000 to local nonprofit organizations in NH that serve residents dealing with opioid addiction with evidence-based prevention, treatment or recovery services. 

“Given the severity of the drug crisis in New Hampshire, we felt it was important to step up and support those organizations helping to prevent and treat individuals and their families affected by opioid misuse in the state,” says William Brewster, M.D., Vice President of New Hampshire Regional Market at Harvard Pilgrim Health Care.  “Addiction is a disease, and with New Hampshire leading the nation in overdose deaths per capita for fentanyl, we hope this grants program will help organizations providing health, hope and support for freedom from addiction.”

Grant funds must be used to:

  • Provide evidence-based prevention, treatment or recovery services to those with opioid addiction
  • Serve individuals from New Hampshire
  • Support projects that prove sustainability and provide measurement of results from current efforts as well as a plan to track and measure proposed services to be covered by grant.

The applicant must be a non-profit, 501(c)(3) program or organization. Grant requests can be for $5,000 or $10,000. Grants will be awarded in September 2018, with the expectation that funds will be used by March 30, 2019.

To receive an application and for further information, email Susan_Walsh@harvardpilgrim.org. All program questions should be directed to Susan Walsh by June 15, 2018. Deadline for applications is Friday, June 29, 2018 by 4:00 p.m.  All applicants will be notified of award decisions by September 4, 2018.

 

All Stories